CheckRare: Reducing Barriers to Participate in Clinical Trials
Clincierge CEO Scott Gray recently spoke to CheckRare on the unique challenges of patients in rare disease clinical trials and ways to reduce barriers to participation.
Clincierge CEO Scott Gray recently spoke to CheckRare on the unique challenges of patients in rare disease clinical trials and ways to reduce barriers to participation.
Clincierge CEO Scott Gray recently joined the Empowered Patient Podcast with Karen Jagoda to discuss specialized patient concierge solutions for participants in rare disease clinical trials. He also explained why Clincierge’s 2023 Rare Disease Day sponsorship felt so natural.
Rare Disease Day 2023 is celebrated on Tuesday, February 28, and raises awareness of the over 7,000 identified rare diseases. Our latest blog will help you learn more about what constitutes a “rare” disease and how patient concierge services can improve recruitment and increase retention in your clinical trials.
Clincierge CEO Scott Gray recently joined the Empowered Patient Podcast with Karen Jagoda to discuss specialized patient concierge solutions for participants in rare disease clinical trials. He also explained why Clincierge’s 2023 Rare Disease Day sponsorship felt so natural.
Health IT Issues recently cited Clincierge CEO Scott Gray‘s article Modernizing Clinical Trials in 2023 with Patient Centricity as one of the most-read thought leader posts for December 2022.
Clincierge CEO Scott Gray shares his experiences and best practices for providing patient concierge support services to pediatric clinical trial patients and their caregivers in this new Clinical Research News article.
In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.
In this Health IT Answers article, Scott Gray, CEO, discusses modern patient-centric methods to remove barriers and increase access in rare disease clinical trials, such as prioritizing patient engagement, embracing digital solutions, and investing in supplemental patient support services.
Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …
Amplifying the Voice of the Patient in Rare Disease Trials Read More »
In this SCRS Talks podcast, Scott Gray, CEO, highlights statistics from an independent, IRB-approved survey of patients and caregivers regarding participation in clinical trials. Learn about the financial risks of patient dropouts and trial delays, plus practical strategies for making trial participation easier and encouraging patient retention.